Professional Documents
Culture Documents
Drugs - OB
Drugs - OB
Drugs - OB
1. Induction of labor: history of precipitous labor and delivery, postterm pregnancy, prolonged
pregnancy with placental insufficiency, prolonged rupture of membranes, PIH
2. Augmentation of labor: dysfunctional labor (prolonged latent phase or arrest of descent)
3. Control of postpartum atony and hemorrhage: Reduce risk of postpartum hemorrhage
4. Control of post surgical hemorrhage: Cesarean section
5. Induction of therapeutic abortion
Actions:
• Prostaglandin E2
• Uterine and gastrointestinal smooth muscle stimulation
• Cervical softening and dilation
• Increases frequency and strength of uterine contractions
Uses:
• Expel uterine contents = intrauterine fetal death, hydatidiform mole, missed spontaneous
miscarriage, second trimester abortion
• Used together with oxytocin\
Therapeutic Outcomes:
• Cervical softening and dilatation before labor
• Evacuation of uterine contents
Side Effects:
• Nausea and vomiting; diarrhea
• Fever
• Orthostatic hypotension
• Arrhythmia
Side Effects:
• Nausea, vomiting, abdominal cramping
• Hypertension
Drug Interactions:
• Inhibitions of Prolactin (breastfeeding) = ergonovine only
• Caudal or spinal anesthesia = hypertension and headcahes
Actions:
• Stimulates the smooth muscles of uterus, blood vessels and mammary glands
• Third trimester = active labor
Uses:
• Inducing labor at term and augmenting uterine contractions (first and second stages of labor)
• Postpartum to control uterine atony and postpartum hemorrhage
• Promote milk letdown (intranasally)
• Treat breast engorgement during lactation
Therapeutic Outcomes:
• Initiation of labor
• Support of uterine contractions (1st and 2nd stages of labor)
• Control of postpartum bleeding
• Milk letdown for nursing mothers
Side Effects:
• Uterine contractions
• Nausea and vomiting
• Fetal distress
• Hypertension, hypotension
• Water intoxication
• Dehydration
• Postpartum hemorrhage
Drug Interactions:
• Anesthetics = blood pressure and pulse rate changes (if containing epinephrine, report
diaphoresis, fever, chest pain, palpitations, severe throbbing headache)
Uses: Primarily to delay or prevent preterm labor and delivery in selected patients
Actions:
• Beta-adrenergic receptor stimulants (predominantly beta-2, plus beta-1 for higher doses)
• Beta-2 = relaxation of uterine, bronchial, and vascular smooth muscle
• Beta-1 = increased heart rate
• Regulate fate and carbohydrate metabolism
Side effects:
• Tachycardia, palpitations, hypertension, and hypotension
• Tremors
• Nervousness, anxiety, restlessness, headache
• Nausea, vomiting
• Dizziness
• Hyperglycemia
• Electrolyte imbalance
• Neonatal adverse effects: hyperglycemia, followed by hypoglycemia, hypocalcemia,
hypotension, and paralytic ileus
Drug interactions:
• Enhance toxic effects: tricyclic antidepressant, sympathomimetic agents
• Reduce therapeutic effects: beta-adrenergic blocking agents
• Corticosteroids: pulmonary edema
• Antihypertensive agents: reduce therapeutic effects of antihypertensive agents
• General anesthesia: additional hypotensive effects
Other Agents
Actions:
• Structurally similar to natural estrogen
• Binds to estrogen receptors = reduce receptors available to circulating estrogen = receptors send
signal to hypothalamus and pituitary gland indicating lack of circulating estrogen = LH and
FSH = release of ova
Side Effects:
• Nausea and vomiting, diarrhea, constipation, hot flashes, abdominal cramps
• Severe abdominal cramps, visual disturbances, dizziness
Actions:
• Normal = 1.8 to 3 mEq/L
• 4 mEq/L = depress central nervous system and blocks peripheral nerve transmission =
anticonvulsant effects and smooth muscle relaxation
Uses:
• Control of seizure activity
• Inhibit premature labor in patients who could not tolerate ritodrine
• 3 – 5 mEq/L = side effects rare from hypermagnesemia
• 5 – 8 mEq/L = increasing signs of toxicity
• Early signs of maternal toxicity = complaints of “feeling hot all over”, “being thirsty all the
time”, flushed skin color, and diaphoresis
• May become hypotensive, have depressed patellar, radial and biceps reflexes, have flaccid
muscles
• Later signs of hypermagnesemia = CNS depression (first by anxiety, followed by confusion,
lethargy, and drowsiness
• If continue to increase = cardiac depression and respiratory paralysis
• For patients with impaired renal function and urine output less than 100 mL for the past 4 hours
= use with extreme caution
Therapeutic Outcomes:
• Elimination of seizure activity
• Arrest of preterm labor
Side effects:
• Deep tendon reflexes = absent
• Decreased urine output
• Decreases respiratory rate, blood pressure, fetal heart rate (fetal distress)
• Confusion
• Neonates = hypotension, hyporeflexia, respiratory depression
Drug Interactions:
• CNS depressants = potentiate CNS depressant effects of MgSO4 (barbiturates, analgesics,
general anesthetics, tranquilizers, and alcohol
• Neuromuscular blocking agents = concurrent use with MgSO4 will further depress muscular
activity
Actions:
• Suppresses stimulation of active immunity by Rh positive foreign red blood cells
• Prevent Rh hemolytic disease of the newborn
Side Effects:
• Localized tenderness
• Feve, arthralgia, generalized aches, pains
• Urticaria, tachycardia, hypotension
Therapeutic Outcomes:
• Prevention of postpartum gonorrhea or Chlamydia eye infection
Side Effects:
• Mild conjunctivitis
Actions:
• Vitamin K (fat-soluble vitamin) = production of blood clotting factors: prothrombin (factor II),
proconvertin (factor VII), plasma thromboplastin componet (factor IX), and Stuart factor (factor
X)
Uses:
• Administered prophylactically against hemorrhagic disease of the newborn
Side Effects:
• Bruising, hemorrhage (petechiae, generalized ecchymosis or bleeding from umbilical stump,
circumcision site, nose or GIT